24 HR minocycline 40 MG (as minocycline hydrochloride) Extended Release Oral Capsule
- RxCUI
- 2706371
- RxNorm name
- 24 HR minocycline 40 MG (as minocycline hydrochloride) Extended Release Oral Capsule
- Display name
- 24 HR minocycline 40 MG (as minocycline hydrochloride) Extended Release Oral Capsule
- Full name
- 24 HR minocycline 40 MG (as minocycline hydrochloride) Extended Release Oral Capsule
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:38:46
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| EMROSI | MINOCYCLINE HYDROCHLORIDE EXTENDED-RELEASE | Journey Medical Corporation | 0899eb25-8807-037c-f66c-141a2696b1c0 | 2025-04-22 | Warnings, Adverse reactions | 2706371 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 0899eb25-8807-037c-f66c-141a2696b1c0 | minocycline 40 MG 24 HR Extended Release Oral Capsule [PSN] · 24 HR minocycline 40 MG Extended Release Oral Capsule [SCD] · 24 HR minocycline 40 MG (as minocycline hydrochloride) Extended Release Oral Capsule [SY] | 3 | 5 | These highlights do not include all the information needed to use EMROSI safely and effectively. See full prescribing information for EMROSI. EMROSI TM (minocycline hydrochloride) extended-release capsules, for oral use Initial U.S. Approval: 1971 | 20250422 |